References
- Arjomand A . Accelerator mass spectrometry-enabled studies: current status and future prospects. Bioanalysis2(3), 519–541(2010).
- Lappin G , SeymourM, YoungG, HigtonD, HillH. AMS method validation for quantitation in pharmacokinetic studies with concomitant extravascular and intravenous administration. Bioanalysis3(4), 393–405 (2011).
- Lan G , LiJ, KasserraCet al. Precision and accuracy in the quantitative analysis of biological sample by accelerator mass spectrometry: application in microdose absolute bioavailabilty studies. Anal. Chem. 83, 5607–5616 (2011).
- Xu X , DuekerS, ChristopherLet al. Overcoming bioanalytical challenges in an Onglyza® intraveneous 14C microdose absolute bioavailability study with accelerator MS. Bioanalysis4(15), 1855–1870 (2012).
- Higton D , YoungG, TimmermanP, AbbottR, KnutssonM, SvenssonL. European Bioanalysis Forum recommendation: scientific validation of quantification by accelerator mass spectrometry. Bioanalysis4(22), 2669–2679 (2012).
- Timmerman P , KallMA, GordonB, LaaskoS, FreislebenA, HuckerR. Best practices in a tiered approach to metabolite quantification: views and recommendations of the European Bioanalysis Forum. Bioanalysis2(7), 1185–1194 (2010).
- Young G , CorlessS, FelgateC, ColthupP. Comparison of a 250kV single-stage accelerator mass spectrometer with a 5MV accelerator mass spectrometer – fitness for purpose in bioanalysis. Rapid Comm. Mass Spectrom. 22, 4035–4042 (2008).
- Lappin G , SeymourM, YoungG, HigtonD, HillH. An AMS method to determine analyte recovery from pharmacokinetic studies with concomitant extravascular and intravenous administration. Bioanalysis3(4), 407–410 (2011).
- Rowland M . Microdosing: a critical assessment of human data. J. Pharm. Sci. 101, 4067–4074 (2012).
- Nedderman A . The use of accelerator MS in support of MIST. Bioanalysis3(24), 2695–2699 (2011).
- Lappin G , SeymourM, GrossG, J⊘rgensenM, KallM, Kvᴂrn⊘L. Meeting MIST regulations: human metabolism in phase 1 using AMS and a tiered bioanalytical approach. Bioanalysis4(4), 407–416, (2012).
- Yi P , Luffer-AtlasD. A radiocalibration method with pseudointernal standard to estimate circulating metabolite concentrations. Bioanalysis2(7), 1195–1210 (2010).
- Ma S , ChowdhuryS. Analytical strategies for assessment of human metabolites in preclinical safety testing. Anal. Chem. 83, 5028–5036 (2011).
Website
- Mandatory requirements for an effective application. www.tga.gov.au/industry/pm-argpm-requirements.htm